A new Listerine product is making a big splash after a short time on the market

Article Abstract:

Listerine's new Listerine Pocket Paks, paper-thin strips that melt on the tongue, are selling well after a short time on the market. Pfizer has distributed Pocket Paks at the Emmys, at Manhattan movie theaters, at the Chicago Film Festival and the Head of the Charles regatta, and will distribute even more at the Oscars and the Golden Globes.

Author: Hays, Constance L.
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2001
Pharmaceutical Preparation Manufacturing, Toilet Preparation Manufacturing, Advertising, Toilet preparations, Marketing/Advertising Methods, Pharmaceutical Preparations, Mouthwashes, Drugs, Marketing, Toiletries industry

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

New Study Links Pfizer's Bextra, Similar to Vioxx, To Heart Attacks

Article Abstract:

Preliminary data from a new clinical study, show that Bextra, a Cox-2 inhibitor from Pfizer Inc., more than doubled the number of heart attacks or strokes in patients. The results are similar to those reported in studies of another Cox-2 inhibitor, Vioxx, from Merck and Company, which was taken off the market in September.

Author: Harris, By Gardiner
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Product standards, safety, & recalls, Financial management, Science & research, Securities issued, listed, Research, Product defects and recalls, Finance, Reports, Risk factors, Clinical trials, Securities, Heart diseases, COX-2 inhibitors, Company securities, Company financing, American Heart Association, Vioxx (Medication), Merck & Company Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

F.D.A. Urges Doctors to Limit Their Prescriptions for a Pair of Popular Painkillers

Article Abstract:

The Food and Drug Administration is planning to convene an advisory group to determine whether painkillers Bextra and Celebrex, both from Pfizer Inc., should be taken off the market. In the meantime, the agency is recommending that doctors limit prescribing the drugs.

Author: Berenson, Alex, Harris, Gardiner
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Legal issues & crime, Government regulation (cont), Government regulation, Legal/Government Regulation, Laws, regulations and rules, Nonsteroidal anti-inflammatory drugs, Nonsteroidal anti-inflammatory agents, Dosage and administration, United States. Food and Drug Administration, Celebrex (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Pharmaceutical industry, Product information, Pfizer Inc., PFE, Complications and side effects, Bextra (Medication)
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.